How ACO Conveners Are Changing the Medicare Shared Savings Program (MSSP) Behind the Scenes
Why It Matters
If conveners are systematically aggregating low‑cost clinicians to capture bonuses, Medicare’s shared‑savings model could be exploited, prompting regulators to tighten oversight and redesign incentives.
Key Takeaways
- •Third‑party conveners now manage 23% of MSSP beneficiaries.
- •Dispersed convenor ACOs grew from 9% to 45% beneficiaries.
- •These dispersed ACOs earned $171 per beneficiary, far above peers.
- •Quality scores remained similar across convenor and non‑convenor ACOs.
- •Evidence suggests conveners cherry‑pick low‑cost clinicians to beat benchmarks.
Summary
The episode examines a new Health Affairs study on third‑party conveners reshaping Medicare’s Shared Savings Program (MSSP). Researchers tracked ACOs from 2012‑2021, finding conveners expanded from 11% to roughly 23% of program beneficiaries and increasingly linked clinicians across distant states.
Key findings show geographically dispersed convenor‑run ACOs rose from 9% to 45% of beneficiaries, while locally‑focused ACOs dwindled to 4%. These dispersed networks captured the highest shared‑savings bonuses—about $171 per beneficiary annually—far outpacing local convenor ACOs ($95) and non‑convenor groups. Despite higher earnings, their quality scores matched those of traditional ACOs.
Dr. Adam Marovitz highlighted that original ACO concepts envisioned local, integrated physician‑hospital networks, not national aggregators. He cited tools like Milleman’s “ACO Builder,” which map low‑cost physicians for network assembly, suggesting strategic cherry‑picking. The study also noted that dispersed convenors’ patients spent roughly $400 less than regional benchmarks, reinforcing the selection hypothesis.
The findings raise policy concerns: conveners may be gaming benchmarks rather than improving care, undermining the MSSP’s intent to align incentives with clinicians. Regulators may need tighter transparency and oversight to ensure ACOs reflect genuine clinical integration rather than cost arbitrage, preserving the program’s cost‑containment goals.
Comments
Want to join the conversation?
Loading comments...